IXICO PLC (IXI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, IXICO PLC (IXI) has a cash flow conversion efficiency ratio of -0.118x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.26 Million ≈ $-153.91 USD) by net assets (GBX10.72 Million ≈ $1.30K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See IXI equity financing ratio to measure how much of total assets are equity-financed.
IXICO PLC - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how IXICO PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check IXI cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
IXICO PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IXICO PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Panamax AG
F:ICP
|
N/A |
|
Springer Nature AG & Co KGaA
XETRA:SPG
|
N/A |
|
Kiromic Biopharma Inc
NASDAQ:KRBP
|
0.290x |
|
TRELLUS HEALTH LS -0006
F:85Q
|
N/A |
|
TEVANO SYSTEMS HLDGS INC.
F:7RBA
|
N/A |
|
Northern Bear Plc
LSE:NTBR
|
0.121x |
|
Inspiration Healthcare Group PLC
LSE:IHC
|
0.222x |
|
Oriole Resources PLC
LSE:ORR
|
-0.058x |
Annual Cash Flow Conversion Efficiency for IXICO PLC (1993–2025)
The table below shows the annual cash flow conversion efficiency of IXICO PLC from 1993 to 2025. For the full company profile with market capitalisation and key ratios, see IXI stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | GBX11.74 Million ≈ $1.43K |
GBX-883.00K ≈ $-107.44 |
-0.075x | +58.89% |
| 2024-09-30 | GBX9.46 Million ≈ $1.15K |
GBX-1.73 Million ≈ $-210.73 |
-0.183x | -792.77% |
| 2023-09-30 | GBX11.43 Million ≈ $1.39K |
GBX302.00K ≈ $36.74 |
0.026x | -76.92% |
| 2022-09-30 | GBX12.49 Million ≈ $1.52K |
GBX1.43 Million ≈ $173.99 |
0.114x | +114.00% |
| 2021-09-30 | GBX11.48 Million ≈ $1.40K |
GBX614.00K ≈ $74.71 |
0.053x | -74.82% |
| 2020-09-30 | GBX9.12 Million ≈ $1.11K |
GBX1.94 Million ≈ $235.68 |
0.212x | +1393.93% |
| 2019-09-30 | GBX7.92 Million ≈ $963.51 |
GBX-130.00K ≈ $-15.82 |
-0.016x | -133.88% |
| 2018-09-30 | GBX7.33 Million ≈ $891.36 |
GBX355.00K ≈ $43.19 |
0.048x | +120.23% |
| 2017-09-30 | GBX2.69 Million ≈ $327.17 |
GBX-644.00K ≈ $-78.36 |
-0.239x | +36.26% |
| 2016-09-30 | GBX4.08 Million ≈ $497.03 |
GBX-1.53 Million ≈ $-186.77 |
-0.376x | +22.65% |
| 2015-09-30 | GBX2.71 Million ≈ $329.61 |
GBX-1.32 Million ≈ $-160.12 |
-0.486x | -8.58% |
| 2014-09-30 | GBX3.81 Million ≈ $463.81 |
GBX-1.71 Million ≈ $-207.51 |
-0.447x | +63.80% |
| 2013-09-30 | GBX3.59 Million ≈ $436.92 |
GBX-4.44 Million ≈ $-539.98 |
-1.236x | -15.05% |
| 2012-09-30 | GBX8.37 Million ≈ $1.02K |
GBX-9.00 Million ≈ $-1.09K |
-1.074x | -166.95% |
| 2011-09-30 | GBX15.96 Million ≈ $1.94K |
GBX-6.42 Million ≈ $-781.62 |
-0.402x | -112.69% |
| 2010-09-30 | GBX23.48 Million ≈ $2.86K |
GBX-4.44 Million ≈ $-540.46 |
-0.189x | +82.54% |
| 2009-09-30 | GBX3.14 Million ≈ $381.68 |
GBX-3.40 Million ≈ $-413.68 |
-1.084x | -200.60% |
| 2008-09-30 | GBX7.16 Million ≈ $871.29 |
GBX-2.58 Million ≈ $-314.15 |
-0.361x | +81.49% |
| 2007-09-30 | GBX2.80 Million ≈ $340.80 |
GBX-5.46 Million ≈ $-663.84 |
-1.948x | -115.77% |
| 2006-08-31 | GBX6.48 Million ≈ $788.31 |
GBX-5.85 Million ≈ $-711.65 |
-0.903x | -181.11% |
| 2005-08-31 | GBX11.81 Million ≈ $1.44K |
GBX-3.79 Million ≈ $-461.62 |
-0.321x | +70.85% |
| 2004-08-31 | GBX5.29 Million ≈ $643.88 |
GBX-5.83 Million ≈ $-709.46 |
-1.102x | -56.48% |
| 2003-08-31 | GBX5.10 Million ≈ $620.16 |
GBX-3.59 Million ≈ $-436.68 |
-0.704x | -55.28% |
| 2002-08-31 | GBX10.29 Million ≈ $1.25K |
GBX-4.66 Million ≈ $-567.47 |
-0.453x | -126.95% |
| 2001-08-31 | GBX13.09 Million ≈ $1.59K |
GBX-2.62 Million ≈ $-318.29 |
-0.200x | +56.81% |
| 2000-08-31 | GBX4.76 Million ≈ $579.15 |
GBX-2.20 Million ≈ $-267.92 |
-0.463x | +47.78% |
| 1999-08-31 | GBX2.06 Million ≈ $250.64 |
GBX-1.82 Million ≈ $-222.05 |
-0.886x | +33.54% |
| 1998-08-31 | GBX2.95 Million ≈ $359.42 |
GBX-3.94 Million ≈ $-479.14 |
-1.333x | -244.33% |
| 1997-08-31 | GBX6.48 Million ≈ $788.19 |
GBX-2.51 Million ≈ $-305.15 |
-0.387x | -430.08% |
| 1996-08-31 | GBX9.54 Million ≈ $1.16K |
GBX-697.00K ≈ $-84.80 |
-0.073x | +45.55% |
| 1995-08-31 | GBX-2.52 Million ≈ $-306.61 |
GBX338.00K ≈ $41.12 |
-0.134x | -118.43% |
| 1994-08-31 | GBX-2.71 Million ≈ $-329.61 |
GBX-1.97 Million ≈ $-239.81 |
0.728x | -51.56% |
| 1993-08-31 | GBX-512.00K ≈ $-62.30 |
GBX-769.00K ≈ $-93.57 |
1.502x | -- |
About IXICO PLC
IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imag… Read more